As of 30 Sep 2025, 15 institutional investors reported holding $142,653,005 in principal (par value) of GOSSAMER BIO INC - NOTE 5.000% 6/0.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | $142,653,005 | $120,891,211 | -$3,070,130 | 69.5% | 15 |
| 2025 Q2 | $151,898,880 | $94,158,395 | -$6,577,623 | 52.47% | 13 |
| 2025 Q1 | $166,276,850 | $106,833,547 | -$1,128,807 | 56.0% | 13 |
| 2024 Q4 | $172,449,850 | $105,507,106 | -$439,375 | 53.99% | 14 |
| 2024 Q3 | $173,427,850 | $91,358,329 | -$505,199 | 52.36% | 14 |
| 2024 Q2 | $174,427,850 | $96,670,884 | -$752,032 | 49.14% | 14 |
| 2024 Q1 | $175,927,850 | $78,772,359 | -$8,738,317,375 | 40.0% | 13 |
| 2023 Q4 | $188,786,978 | $70,928,514 | +$7,178,077 | 37.46% | 13 |
| 2023 Q3 | $169,080,828 | $75,590,270 | +$418,933 | 39.61% | 14 |
| 2023 Q2 | $168,582,983 | $58,393,690 | -$2,952,463 | 30.65% | 14 |
| 2023 Q1 | $198,268,483 | $57,344,867 | -$3,104,300 | 27.59% | 18 |
| 2022 Q4 | $210,389,850 | $68,739,390 | -$6,327,082 | 32.35% | 18 |
| 2022 Q3 | $217,354,850 | $229,093,000 | +$9,445,314 | 103.25% | 23 |
| 2022 Q2 | $211,054,350 | $162,925,000 | -$8,295,107 | 74.75% | 21 |
| 2022 Q1 | $212,217,850 | $182,239,000 | -$3,082,458 | 80.87% | 23 |
| 2021 Q4 | $211,455,850 | $219,654,000 | -$934,561 | 98.0% | 23 |
| 2021 Q3 | $209,906,850 | $217,371,462 | +$2,909,827 | 103.87% | 23 |
| 2021 Q2 | $207,953,250 | $167,292,324 | +$11,943,418 | 80.32% | 25 |
| 2021 Q1 | $191,143,250 | $172,308,584 | -$11,653,434 | 89.75% | 25 |
| 2020 Q4 | $203,806,000 | $185,211,000 | -$1,432,829 | 90.59% | 23 |
| 2020 Q3 | $208,056,000 | $214,786,000 | +$31,360,555 | 103.05% | 28 |
| 2020 Q2 | $171,551,000 | $172,861,000 | +$172,861,000 | 100.7% | 27 |